ppeptidewhy
Side by side

Compare peptides.

See why people discuss them, what the evidence supports, and where amount information comes from.

Choose two compounds

Add up to four if you need to. Evidence labels apply to specific claims and products.

Compare more (up to four)

Melanocortin signaling

PT-141

Also called bremelanotide, a compound that activates melanocortin receptors—message receivers involved in several body functions.

Why people are interested

PT-141 is discussed for sexual desire because bremelanotide is the active ingredient in an approved prescription product for a narrowly defined condition.

What the research supports

The FDA-approved Vyleesi autoinjector is for acquired, generalized low sexual desire in premenopausal women. Its evidence and approval do not automatically apply to a dry PT-141 research vial or to other populations.

Clinical or label amounts

Prescription product label

1.75 mg

As needed in the labeled population

Specific to the named study or medicine, not this research vial.

Vyleesi (bremelanotide) prescribing information ↗

Publicly reported amounts

Amount in one post: 1.3 mg on one occasion

One checked post, not a typical amount or a recommendation.

Public reports and source limits →
Read the full PT-141 profile and sources →
Metabolic & appetite

Tirzepatide

Tirzepatide acts on GIP and GLP-1 receptors. It has been studied in human medicine products for blood sugar and metabolic effects.

Why people are interested

Tirzepatide is well known because prescription versions are used for type 2 diabetes, chronic weight management, and certain sleep-apnea patients. JD-2TR is a seller code associated with tirzepatide in listed batch reports.

What the research supports

The strongest evidence belongs to manufactured prescription tirzepatide products studied in clinical trials. FDA approval applies to those products and specific indications, not automatically to a research-only JD-2TR vial.

Clinical or label amounts

Prescription product label

2.5–15 mg

Once weekly in adults

Specific to the named study or medicine, not this research vial.

Mounjaro prescribing information (2026) ↗

Publicly reported amounts

Amount in one post: 2.5 mg each time from a stated 10 mg dry vial

One checked post, not a typical amount or a recommendation.

Public reports and source limits →
Read the full Tirzepatide profile and sources →

FDA-approved uses belong to named prescription products and indications; they do not transfer to an online research vial. Human, animal, cell, and anecdotal evidence are different. How we check sources →